

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.14257250 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.14257250 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.67980345 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.67980345 |
| 5 | nuclear pore complex assembly (GO:0051292) | 6.48749161 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.75292153 |
| 7 | nuclear pore organization (GO:0006999) | 5.62834297 |
| 8 | mitotic sister chromatid cohesion (GO:0007064) | 5.33851164 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.27446459 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.07387550 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.06594324 |
| 12 | protein localization to kinetochore (GO:0034501) | 5.05480243 |
| 13 | cysteine metabolic process (GO:0006534) | 4.94129774 |
| 14 | bile acid biosynthetic process (GO:0006699) | 4.92763317 |
| 15 | pore complex assembly (GO:0046931) | 4.92287848 |
| 16 | protein localization to chromosome, centromeric region (GO:0071459) | 4.87732746 |
| 17 | sister chromatid segregation (GO:0000819) | 4.70661283 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.68392601 |
| 19 | protein carboxylation (GO:0018214) | 4.68392601 |
| 20 | mitotic sister chromatid segregation (GO:0000070) | 4.66031621 |
| 21 | cellular glucuronidation (GO:0052695) | 4.55850107 |
| 22 | fatty acid elongation (GO:0030497) | 4.55409845 |
| 23 | tryptophan catabolic process (GO:0006569) | 4.54245045 |
| 24 | indole-containing compound catabolic process (GO:0042436) | 4.54245045 |
| 25 | indolalkylamine catabolic process (GO:0046218) | 4.54245045 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.51277448 |
| 27 | mitotic chromosome condensation (GO:0007076) | 4.50456668 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.49901225 |
| 29 | mitotic metaphase plate congression (GO:0007080) | 4.48727786 |
| 30 | tryptophan metabolic process (GO:0006568) | 4.47056705 |
| 31 | kynurenine metabolic process (GO:0070189) | 4.35513086 |
| 32 | purine ribonucleotide transport (GO:0015868) | 4.31197719 |
| 33 | regulation of sister chromatid cohesion (GO:0007063) | 4.30440730 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.29389946 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 4.28833054 |
| 36 | urea cycle (GO:0000050) | 4.27988306 |
| 37 | urea metabolic process (GO:0019627) | 4.27988306 |
| 38 | regulation of fibrinolysis (GO:0051917) | 4.27560487 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.25340651 |
| 40 | complement activation, alternative pathway (GO:0006957) | 4.23360280 |
| 41 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.23223864 |
| 42 | metaphase plate congression (GO:0051310) | 4.21315759 |
| 43 | aldehyde catabolic process (GO:0046185) | 4.19576800 |
| 44 | bile acid metabolic process (GO:0008206) | 4.19313184 |
| 45 | serine family amino acid biosynthetic process (GO:0009070) | 4.15876876 |
| 46 | glucuronate metabolic process (GO:0019585) | 4.12108309 |
| 47 | uronic acid metabolic process (GO:0006063) | 4.12108309 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 4.09984772 |
| 49 | lysine metabolic process (GO:0006553) | 4.09138254 |
| 50 | lysine catabolic process (GO:0006554) | 4.09138254 |
| 51 | reverse cholesterol transport (GO:0043691) | 4.07367956 |
| 52 | nucleotide transmembrane transport (GO:1901679) | 4.06820241 |
| 53 | regulation of complement activation (GO:0030449) | 4.03513198 |
| 54 | purine nucleotide transport (GO:0015865) | 4.00325272 |
| 55 | L-serine metabolic process (GO:0006563) | 3.96900579 |
| 56 | DNA replication checkpoint (GO:0000076) | 3.96392627 |
| 57 | mitotic nuclear envelope disassembly (GO:0007077) | 3.96186534 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 3.93482638 |
| 59 | protein-lipid complex remodeling (GO:0034368) | 3.92773360 |
| 60 | macromolecular complex remodeling (GO:0034367) | 3.92773360 |
| 61 | plasma lipoprotein particle remodeling (GO:0034369) | 3.92773360 |
| 62 | ribosome assembly (GO:0042255) | 3.87879526 |
| 63 | very long-chain fatty acid metabolic process (GO:0000038) | 3.86573032 |
| 64 | nitrogen cycle metabolic process (GO:0071941) | 3.86102574 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 3.83233065 |
| 66 | alpha-amino acid catabolic process (GO:1901606) | 3.83104364 |
| 67 | DNA topological change (GO:0006265) | 3.83096690 |
| 68 | establishment of integrated proviral latency (GO:0075713) | 3.81829726 |
| 69 | homocysteine metabolic process (GO:0050667) | 3.79429724 |
| 70 | non-recombinational repair (GO:0000726) | 3.79355627 |
| 71 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.79355627 |
| 72 | regulation of mitotic spindle organization (GO:0060236) | 3.78680724 |
| 73 | cholesterol biosynthetic process (GO:0006695) | 3.78445942 |
| 74 | serine family amino acid catabolic process (GO:0009071) | 3.78127710 |
| 75 | regulation of triglyceride catabolic process (GO:0010896) | 3.76774841 |
| 76 | establishment of chromosome localization (GO:0051303) | 3.76717922 |
| 77 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.75833486 |
| 78 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.75373737 |
| 79 | DNA unwinding involved in DNA replication (GO:0006268) | 3.70500162 |
| 80 | coenzyme catabolic process (GO:0009109) | 3.70157763 |
| 81 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.69492570 |
| 82 | serine family amino acid metabolic process (GO:0009069) | 3.67084843 |
| 83 | membrane disassembly (GO:0030397) | 3.66348166 |
| 84 | nuclear envelope disassembly (GO:0051081) | 3.66348166 |
| 85 | COPII vesicle coating (GO:0048208) | 3.65751040 |
| 86 | regulation of cholesterol metabolic process (GO:0090181) | 3.65263868 |
| 87 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.62373745 |
| 88 | CENP-A containing nucleosome assembly (GO:0034080) | 3.62158169 |
| 89 | triglyceride homeostasis (GO:0070328) | 3.61491357 |
| 90 | acylglycerol homeostasis (GO:0055090) | 3.61491357 |
| 91 | cellular modified amino acid catabolic process (GO:0042219) | 3.61064050 |
| 92 | tRNA aminoacylation for protein translation (GO:0006418) | 3.60611766 |
| 93 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.60479457 |
| 94 | spindle checkpoint (GO:0031577) | 3.59283786 |
| 95 | mitotic spindle checkpoint (GO:0071174) | 3.58524313 |
| 96 | fibrinolysis (GO:0042730) | 3.58081027 |
| 97 | amino acid activation (GO:0043038) | 3.55165195 |
| 98 | tRNA aminoacylation (GO:0043039) | 3.55165195 |
| 99 | COPI coating of Golgi vesicle (GO:0048205) | 3.55015580 |
| 100 | Golgi transport vesicle coating (GO:0048200) | 3.55015580 |
| 101 | DNA strand elongation (GO:0022616) | 3.54443766 |
| 102 | chromatin remodeling at centromere (GO:0031055) | 3.51894277 |
| 103 | regulation of DNA endoreduplication (GO:0032875) | 3.51605069 |
| 104 | cellular amino acid catabolic process (GO:0009063) | 3.51022378 |
| 105 | regulation of chromosome segregation (GO:0051983) | 3.49954345 |
| 106 | cofactor catabolic process (GO:0051187) | 3.49668141 |
| 107 | regulation of cholesterol esterification (GO:0010872) | 3.48844810 |
| 108 | DNA ligation (GO:0006266) | 3.48211938 |
| 109 | cholesterol efflux (GO:0033344) | 3.47683624 |
| 110 | kinetochore organization (GO:0051383) | 3.47641449 |
| 111 | protein localization to chromosome (GO:0034502) | 3.45526298 |
| 112 | amino-acid betaine metabolic process (GO:0006577) | 3.41753018 |
| 113 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.41706139 |
| 114 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.41706139 |
| 115 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.41411109 |
| 116 | regulation of spindle organization (GO:0090224) | 3.41144659 |
| 117 | aspartate family amino acid catabolic process (GO:0009068) | 3.41036717 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.39700264 |
| 119 | central nervous system myelination (GO:0022010) | 3.39130805 |
| 120 | axon ensheathment in central nervous system (GO:0032291) | 3.39130805 |
| 121 | ketone body metabolic process (GO:1902224) | 3.38698813 |
| 122 | glycine metabolic process (GO:0006544) | 3.38311848 |
| 123 | negative regulation of chromosome segregation (GO:0051985) | 3.37901645 |
| 124 | spindle assembly checkpoint (GO:0071173) | 3.37802792 |
| 125 | heme transport (GO:0015886) | 3.37533441 |
| 126 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.36825534 |
| 127 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.36825534 |
| 128 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.36825534 |
| 129 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.36825534 |
| 130 | negative regulation of sister chromatid segregation (GO:0033046) | 3.36825534 |
| 131 | DNA double-strand break processing (GO:0000729) | 3.35646192 |
| 132 | sterol biosynthetic process (GO:0016126) | 3.35471050 |
| 133 | mitotic spindle assembly checkpoint (GO:0007094) | 3.35015508 |
| 134 | glutamate metabolic process (GO:0006536) | 3.32843100 |
| 135 | negative regulation of cholesterol transport (GO:0032375) | 3.31962836 |
| 136 | negative regulation of sterol transport (GO:0032372) | 3.31962836 |
| 137 | adenine nucleotide transport (GO:0051503) | 3.30732364 |
| 138 | bile acid and bile salt transport (GO:0015721) | 3.30194386 |
| 139 | ethanol oxidation (GO:0006069) | 3.29365995 |
| 140 | thioester biosynthetic process (GO:0035384) | 3.29241970 |
| 141 | acyl-CoA biosynthetic process (GO:0071616) | 3.29241970 |
| 142 | regulation of sister chromatid segregation (GO:0033045) | 3.28436674 |
| 143 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.28436674 |
| 144 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.28436674 |
| 145 | DNA replication-independent nucleosome organization (GO:0034724) | 3.28066428 |
| 146 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.28066428 |
| 147 | low-density lipoprotein particle remodeling (GO:0034374) | 3.27944100 |
| 148 | indolalkylamine metabolic process (GO:0006586) | 3.27833099 |
| 149 | purine nucleobase biosynthetic process (GO:0009113) | 3.26246181 |
| 150 | amine catabolic process (GO:0009310) | 3.25499833 |
| 151 | cellular biogenic amine catabolic process (GO:0042402) | 3.25499833 |
| 152 | cholesterol homeostasis (GO:0042632) | 3.24456708 |
| 153 | sterol homeostasis (GO:0055092) | 3.23265579 |
| 154 | arginine metabolic process (GO:0006525) | 3.22927797 |
| 155 | regulation of centriole replication (GO:0046599) | 3.22757495 |
| 156 | acetyl-CoA metabolic process (GO:0006084) | 3.22419468 |
| 157 | nucleotide transport (GO:0006862) | 3.21666838 |
| 158 | opsonization (GO:0008228) | 3.21635591 |
| 159 | mitotic recombination (GO:0006312) | 3.20606724 |
| 160 | resolution of meiotic recombination intermediates (GO:0000712) | 3.20533579 |
| 161 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.17566168 |
| 162 | phospholipid efflux (GO:0033700) | 3.16201854 |
| 163 | response to nitrosative stress (GO:0051409) | 3.15640404 |
| 164 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.15608031 |
| 165 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.15608031 |
| 166 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.15608031 |
| 167 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.14742063 |
| 168 | sister chromatid cohesion (GO:0007062) | 3.14403986 |
| 169 | formation of translation preinitiation complex (GO:0001731) | 3.14333505 |
| 170 | intestinal cholesterol absorption (GO:0030299) | 3.13375554 |
| 171 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.13282283 |
| 172 | chromosome segregation (GO:0007059) | 3.10635087 |
| 173 | replication fork processing (GO:0031297) | 3.08343716 |
| 174 | telomere maintenance via recombination (GO:0000722) | 3.08089433 |
| 175 | histone H2B ubiquitination (GO:0033523) | 3.07477113 |
| 176 | histone H2A acetylation (GO:0043968) | 3.06459997 |
| 177 | positive regulation of chromosome segregation (GO:0051984) | 3.04015230 |
| 178 | negative regulation of DNA recombination (GO:0045910) | 3.03543779 |
| 179 | IMP biosynthetic process (GO:0006188) | 2.95644872 |
| 180 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.92275862 |
| 181 | nucleobase biosynthetic process (GO:0046112) | 2.92034510 |
| 182 | microtubule depolymerization (GO:0007019) | 2.91713734 |
| 183 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.91334201 |
| 184 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.91334201 |
| 185 | establishment of viral latency (GO:0019043) | 2.90978387 |
| 186 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.90307936 |
| 187 | nuclear envelope organization (GO:0006998) | 2.89874578 |
| 188 | mitotic spindle organization (GO:0007052) | 2.86581305 |
| 189 | ATP-dependent chromatin remodeling (GO:0043044) | 2.84754456 |
| 190 | histone exchange (GO:0043486) | 2.83296298 |
| 191 | DNA packaging (GO:0006323) | 2.80213362 |
| 192 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.80034512 |
| 193 | chromosome condensation (GO:0030261) | 2.79833816 |
| 194 | meiotic chromosome segregation (GO:0045132) | 2.78491284 |
| 195 | ribonucleoprotein complex disassembly (GO:0032988) | 2.76698635 |
| 196 | mitotic cell cycle (GO:0000278) | 2.76400387 |
| 197 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.76228136 |
| 198 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.75485553 |
| 199 | DNA synthesis involved in DNA repair (GO:0000731) | 2.72977133 |
| 200 | DNA geometric change (GO:0032392) | 2.72957036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.53113172 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.32076502 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.72599642 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.67519838 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.66002202 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.38653594 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.40024894 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.17643216 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.07775028 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.00171439 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.99525727 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89433530 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.23951196 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.16707334 |
| 15 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 3.07482239 |
| 16 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.05240936 |
| 17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.99458415 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.91198199 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.89525595 |
| 20 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.81582049 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.76169960 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.47801836 |
| 23 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.37050472 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.32830223 |
| 25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.27140471 |
| 26 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.23986864 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.22802075 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.19281366 |
| 29 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.19023943 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.17798539 |
| 31 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.17051633 |
| 32 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.14966918 |
| 33 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.12577578 |
| 34 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11657758 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.10833555 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.06959606 |
| 37 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.06788026 |
| 38 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.04587158 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.04482239 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00393824 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.99137685 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.97634090 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94429229 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92994808 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.91970113 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91559547 |
| 47 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.90846957 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.87113999 |
| 49 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.81398336 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.81393568 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.77610128 |
| 52 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.74491313 |
| 53 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.74324869 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.72827483 |
| 55 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.72380135 |
| 56 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.72010735 |
| 57 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71797819 |
| 58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.71777947 |
| 59 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67775265 |
| 60 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.67354038 |
| 61 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.65376393 |
| 62 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63576267 |
| 63 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.63128378 |
| 64 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.62291265 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.60935105 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.60935105 |
| 67 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.54698561 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53848062 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51048670 |
| 70 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.50432494 |
| 71 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.48914436 |
| 72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.45322951 |
| 73 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43162388 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.42863550 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41786825 |
| 76 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.41325726 |
| 77 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.38649267 |
| 78 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37214044 |
| 79 | FUS_26573619_Chip-Seq_HEK293_Human | 1.37137405 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.34198883 |
| 81 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30617004 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29931234 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.25524120 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24094697 |
| 85 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22338187 |
| 86 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21585359 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19337207 |
| 88 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15513015 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14839982 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13602346 |
| 91 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10994002 |
| 92 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.08940615 |
| 93 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.08455506 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07824629 |
| 95 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.06568392 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05373526 |
| 97 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.04760814 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02866089 |
| 99 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02562931 |
| 100 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02441920 |
| 101 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.01545673 |
| 102 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99676367 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99328935 |
| 104 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.96892364 |
| 105 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96459471 |
| 106 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95799471 |
| 107 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94753215 |
| 108 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94614786 |
| 109 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93708906 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92054139 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90408449 |
| 112 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89578238 |
| 113 | CJUN_26792858_Chip-Seq_BT549_Human | 0.89121528 |
| 114 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88739611 |
| 115 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88670146 |
| 116 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88621248 |
| 117 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.88345991 |
| 118 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87893423 |
| 119 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.87841270 |
| 120 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86571781 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86471827 |
| 122 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.86445281 |
| 123 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86276289 |
| 124 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.84366979 |
| 125 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.84020887 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83344811 |
| 127 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83173544 |
| 128 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82276387 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82146147 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81755664 |
| 131 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.81733533 |
| 132 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.81639616 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81069922 |
| 134 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79695824 |
| 135 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79473496 |
| 136 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.79147520 |
| 137 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79080096 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78826174 |
| 139 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78794447 |
| 140 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78630161 |
| 141 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.78283691 |
| 142 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78139244 |
| 143 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77925293 |
| 144 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77301554 |
| 145 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76759793 |
| 146 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.76325243 |
| 147 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.74074457 |
| 148 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.73921611 |
| 149 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.73720101 |
| 150 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.73392151 |
| 151 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73320249 |
| 152 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.73051986 |
| 153 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72743365 |
| 154 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72633011 |
| 155 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.71925343 |
| 156 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.71744934 |
| 157 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.71706241 |
| 158 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71571920 |
| 159 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.70419323 |
| 160 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70218559 |
| 161 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.69839284 |
| 162 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68928412 |
| 163 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.68757390 |
| 164 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.67077912 |
| 165 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.67005572 |
| 166 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.67005572 |
| 167 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.66828225 |
| 168 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.66828225 |
| 169 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.66765733 |
| 170 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66136203 |
| 171 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.64614987 |
| 172 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63652571 |
| 173 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.63448115 |
| 174 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.63002698 |
| 175 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.60161183 |
| 176 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.58833549 |
| 177 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.58645189 |
| 178 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.57744085 |
| 179 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54264068 |
| 180 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.53870830 |
| 181 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.53460694 |
| 182 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.52719681 |
| 183 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.52718608 |
| 184 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52712360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.75835421 |
| 2 | MP0005360_urolithiasis | 6.63452316 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 5.05075499 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.01806785 |
| 5 | MP0005365_abnormal_bile_salt | 4.85570519 |
| 6 | MP0010094_abnormal_chromosome_stability | 4.30455275 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.86199009 |
| 8 | MP0003111_abnormal_nucleus_morphology | 3.49508156 |
| 9 | MP0008058_abnormal_DNA_repair | 3.41171216 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 3.37951903 |
| 11 | MP0003693_abnormal_embryo_hatching | 3.29649078 |
| 12 | MP0008057_abnormal_DNA_replication | 3.28236870 |
| 13 | MP0003252_abnormal_bile_duct | 3.11796604 |
| 14 | MP0008932_abnormal_embryonic_tissue | 3.09860852 |
| 15 | MP0003195_calcinosis | 3.08321727 |
| 16 | MP0003077_abnormal_cell_cycle | 2.97406671 |
| 17 | MP0005083_abnormal_biliary_tract | 2.85863864 |
| 18 | MP0009840_abnormal_foam_cell | 2.84771967 |
| 19 | MP0009697_abnormal_copulation | 2.78293650 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.70119969 |
| 21 | MP0005332_abnormal_amino_acid | 2.64211121 |
| 22 | MP0002009_preneoplasia | 2.49039642 |
| 23 | MP0008007_abnormal_cellular_replicative | 2.46811986 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 2.29969446 |
| 25 | MP0001666_abnormal_nutrient_absorption | 2.27352844 |
| 26 | MP0003186_abnormal_redox_activity | 2.11351729 |
| 27 | MP0001730_embryonic_growth_arrest | 2.01036256 |
| 28 | MP0008789_abnormal_olfactory_epithelium | 1.95723218 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 1.91404433 |
| 30 | MP0005380_embryogenesis_phenotype | 1.90702175 |
| 31 | MP0001672_abnormal_embryogenesis/_devel | 1.90702175 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.83825251 |
| 33 | MP0003984_embryonic_growth_retardation | 1.78938252 |
| 34 | MP0005408_hypopigmentation | 1.77952396 |
| 35 | MP0002088_abnormal_embryonic_growth/wei | 1.76402410 |
| 36 | MP0005248_abnormal_Harderian_gland | 1.74971320 |
| 37 | MP0003868_abnormal_feces_composition | 1.74673451 |
| 38 | MP0001697_abnormal_embryo_size | 1.74378957 |
| 39 | MP0000609_abnormal_liver_physiology | 1.72755207 |
| 40 | MP0000350_abnormal_cell_proliferation | 1.72689290 |
| 41 | MP0010307_abnormal_tumor_latency | 1.64422341 |
| 42 | MP0005451_abnormal_body_composition | 1.60846895 |
| 43 | MP0001529_abnormal_vocalization | 1.59455163 |
| 44 | MP0002084_abnormal_developmental_patter | 1.59379420 |
| 45 | MP0001727_abnormal_embryo_implantation | 1.59123889 |
| 46 | MP0003221_abnormal_cardiomyocyte_apopto | 1.58562898 |
| 47 | MP0001293_anophthalmia | 1.56402923 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.55639932 |
| 49 | MP0006072_abnormal_retinal_apoptosis | 1.53963263 |
| 50 | MP0009384_cardiac_valve_regurgitation | 1.53865936 |
| 51 | MP0003385_abnormal_body_wall | 1.53538492 |
| 52 | MP0002102_abnormal_ear_morphology | 1.53199756 |
| 53 | MP0005499_abnormal_olfactory_system | 1.51920490 |
| 54 | MP0005394_taste/olfaction_phenotype | 1.51920490 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.50722829 |
| 56 | MP0003690_abnormal_glial_cell | 1.50424820 |
| 57 | MP0001286_abnormal_eye_development | 1.50372006 |
| 58 | MP0003937_abnormal_limbs/digits/tail_de | 1.50145098 |
| 59 | MP0003786_premature_aging | 1.49836608 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.48027801 |
| 61 | MP0002085_abnormal_embryonic_tissue | 1.48001118 |
| 62 | MP0002080_prenatal_lethality | 1.46460516 |
| 63 | MP0006292_abnormal_olfactory_placode | 1.45780205 |
| 64 | MP0008438_abnormal_cutaneous_collagen | 1.44681030 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.44589274 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.43074493 |
| 67 | MP0000566_synostosis | 1.41935335 |
| 68 | MP0003567_abnormal_fetal_cardiomyocyte | 1.41118888 |
| 69 | MP0000604_amyloidosis | 1.39657120 |
| 70 | MP0000920_abnormal_myelination | 1.37455275 |
| 71 | MP0004197_abnormal_fetal_growth/weight/ | 1.35209485 |
| 72 | MP0003943_abnormal_hepatobiliary_system | 1.34270080 |
| 73 | MP0005187_abnormal_penis_morphology | 1.30988319 |
| 74 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30446455 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 1.30116407 |
| 76 | MP0002086_abnormal_extraembryonic_tissu | 1.28971094 |
| 77 | MP0001764_abnormal_homeostasis | 1.27759228 |
| 78 | MP0003329_amyloid_beta_deposits | 1.25125866 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 1.25052802 |
| 80 | MP0004233_abnormal_muscle_weight | 1.24404625 |
| 81 | MP0002254_reproductive_system_inflammat | 1.24247961 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 1.22278796 |
| 83 | MP0002751_abnormal_autonomic_nervous | 1.21972438 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.19932458 |
| 85 | MP0002697_abnormal_eye_size | 1.19705336 |
| 86 | MP0009643_abnormal_urine_homeostasis | 1.19366821 |
| 87 | MP0009053_abnormal_anal_canal | 1.18647462 |
| 88 | MP0000313_abnormal_cell_death | 1.18195638 |
| 89 | MP0003755_abnormal_palate_morphology | 1.16056677 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 1.13011405 |
| 91 | MP0003935_abnormal_craniofacial_develop | 1.12775617 |
| 92 | MP0002006_tumorigenesis | 1.11047213 |
| 93 | MP0010368_abnormal_lymphatic_system | 1.09559305 |
| 94 | MP0009703_decreased_birth_body | 1.09423702 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 1.09197571 |
| 96 | MP0002233_abnormal_nose_morphology | 1.08164542 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 1.07440602 |
| 98 | MP0000598_abnormal_liver_morphology | 1.04266880 |
| 99 | MP0000579_abnormal_nail_morphology | 1.03814592 |
| 100 | MP0003121_genomic_imprinting | 1.03606898 |
| 101 | MP0002092_abnormal_eye_morphology | 1.03465714 |
| 102 | MP0000358_abnormal_cell_content/ | 1.00988747 |
| 103 | MP0003315_abnormal_perineum_morphology | 0.96284792 |
| 104 | MP0002396_abnormal_hematopoietic_system | 0.96063584 |
| 105 | MP0003861_abnormal_nervous_system | 0.92039645 |
| 106 | MP0009763_increased_sensitivity_to | 0.91564873 |
| 107 | MP0005647_abnormal_sex_gland | 0.89698798 |
| 108 | MP0005391_vision/eye_phenotype | 0.89374642 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.89366523 |
| 110 | MP0000647_abnormal_sebaceous_gland | 0.87400183 |
| 111 | MP0001188_hyperpigmentation | 0.86581697 |
| 112 | MP0001243_abnormal_dermal_layer | 0.85808248 |
| 113 | MP0004043_abnormal_pH_regulation | 0.85799925 |
| 114 | MP0001542_abnormal_bone_strength | 0.84021184 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.83950559 |
| 116 | MP0005253_abnormal_eye_physiology | 0.83880337 |
| 117 | MP0005623_abnormal_meninges_morphology | 0.81288716 |
| 118 | MP0005384_cellular_phenotype | 0.80812938 |
| 119 | MP0002210_abnormal_sex_determination | 0.80127718 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.80026169 |
| 121 | MP0002177_abnormal_outer_ear | 0.79705755 |
| 122 | MP0003941_abnormal_skin_development | 0.78193667 |
| 123 | MP0002295_abnormal_pulmonary_circulatio | 0.78017410 |
| 124 | MP0005164_abnormal_response_to | 0.77611305 |
| 125 | MP0002019_abnormal_tumor_incidence | 0.77386495 |
| 126 | MP0006036_abnormal_mitochondrial_physio | 0.75553857 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.75541159 |
| 128 | MP0000516_abnormal_urinary_system | 0.75451990 |
| 129 | MP0005367_renal/urinary_system_phenotyp | 0.75451990 |
| 130 | MP0008995_early_reproductive_senescence | 0.75410272 |
| 131 | MP0001929_abnormal_gametogenesis | 0.75095400 |
| 132 | MP0005376_homeostasis/metabolism_phenot | 0.75000607 |
| 133 | MP0001145_abnormal_male_reproductive | 0.74702788 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.74411992 |
| 135 | MP0005058_abnormal_lysosome_morphology | 0.74290877 |
| 136 | MP0001661_extended_life_span | 0.74188492 |
| 137 | MP0003300_gastrointestinal_ulcer | 0.74186896 |
| 138 | MP0000432_abnormal_head_morphology | 0.74061895 |
| 139 | MP0005621_abnormal_cell_physiology | 0.74048410 |
| 140 | MP0004134_abnormal_chest_morphology | 0.73935374 |
| 141 | MP0001340_abnormal_eyelid_morphology | 0.72420525 |
| 142 | MP0004808_abnormal_hematopoietic_stem | 0.72380377 |
| 143 | MP0000467_abnormal_esophagus_morphology | 0.72044327 |
| 144 | MP0000490_abnormal_crypts_of | 0.71835597 |
| 145 | MP0004147_increased_porphyrin_level | 0.71672014 |
| 146 | MP0002938_white_spotting | 0.71313389 |
| 147 | MP0001346_abnormal_lacrimal_gland | 0.70761340 |
| 148 | MP0005395_other_phenotype | 0.70503949 |
| 149 | MP0002971_abnormal_brown_adipose | 0.69041295 |
| 150 | MP0001915_intracranial_hemorrhage | 0.69019729 |
| 151 | MP0000462_abnormal_digestive_system | 0.68043179 |
| 152 | MP0006054_spinal_hemorrhage | 0.67854215 |
| 153 | MP0000639_abnormal_adrenal_gland | 0.67605311 |
| 154 | MP0005636_abnormal_mineral_homeostasis | 0.67589139 |
| 155 | MP0005084_abnormal_gallbladder_morpholo | 0.67459484 |
| 156 | MP0002876_abnormal_thyroid_physiology | 0.66946157 |
| 157 | MP0003718_maternal_effect | 0.66433351 |
| 158 | MP0002078_abnormal_glucose_homeostasis | 0.65879959 |
| 159 | MP0009764_decreased_sensitivity_to | 0.64700085 |
| 160 | MP0004272_abnormal_basement_membrane | 0.62372308 |
| 161 | MP0002098_abnormal_vibrissa_morphology | 0.62339555 |
| 162 | MP0000613_abnormal_salivary_gland | 0.61111070 |
| 163 | MP0008469_abnormal_protein_level | 0.60760143 |
| 164 | MP0009642_abnormal_blood_homeostasis | 0.60735652 |
| 165 | MP0003453_abnormal_keratinocyte_physiol | 0.59753695 |
| 166 | MP0002877_abnormal_melanocyte_morpholog | 0.59523844 |
| 167 | MP0001881_abnormal_mammary_gland | 0.58563266 |
| 168 | MP0004883_abnormal_blood_vessel | 0.58170297 |
| 169 | MP0004264_abnormal_extraembryonic_tissu | 0.57586277 |
| 170 | MP0002796_impaired_skin_barrier | 0.57316425 |
| 171 | MP0009672_abnormal_birth_weight | 0.55561060 |
| 172 | MP0002168_other_aberrant_phenotype | 0.54720640 |
| 173 | MP0005023_abnormal_wound_healing | 0.53090612 |
| 174 | MP0005666_abnormal_adipose_tissue | 0.53052177 |
| 175 | MP0000377_abnormal_hair_follicle | 0.51953944 |
| 176 | MP0010678_abnormal_skin_adnexa | 0.50586734 |
| 177 | MP0003632_abnormal_nervous_system | 0.49854824 |
| 178 | MP0005595_abnormal_vascular_smooth | 0.48574354 |
| 179 | MP0008260_abnormal_autophagy | 0.48418788 |
| 180 | MP0003011_delayed_dark_adaptation | 0.48364121 |
| 181 | MP0000230_abnormal_systemic_arterial | 0.47195467 |
| 182 | MP0001944_abnormal_pancreas_morphology | 0.46566856 |
| 183 | MP0000762_abnormal_tongue_morphology | 0.46080950 |
| 184 | MP0004885_abnormal_endolymph | 0.45453430 |
| 185 | MP0005334_abnormal_fat_pad | 0.44875462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.83464660 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.57582618 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.11500012 |
| 4 | Xanthomatosis (HP:0000991) | 5.40780012 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.21143818 |
| 6 | Volvulus (HP:0002580) | 5.09700999 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.00328891 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 4.97498234 |
| 9 | Cortical dysplasia (HP:0002539) | 4.76057054 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.42399000 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.40979827 |
| 12 | Abnormality of methionine metabolism (HP:0010901) | 4.32746769 |
| 13 | Fat malabsorption (HP:0002630) | 4.11630675 |
| 14 | Epidermoid cyst (HP:0200040) | 4.07509670 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.94234361 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.92899596 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 3.91208984 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84563866 |
| 19 | Complement deficiency (HP:0004431) | 3.83089300 |
| 20 | Hyperammonemia (HP:0001987) | 3.71435282 |
| 21 | Increased nuchal translucency (HP:0010880) | 3.65466897 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.62603269 |
| 23 | Hyperglycinemia (HP:0002154) | 3.55170873 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.53840967 |
| 25 | Steatorrhea (HP:0002570) | 3.52952591 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51406469 |
| 27 | Ketosis (HP:0001946) | 3.49481348 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.48725030 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.48725030 |
| 30 | Joint hemorrhage (HP:0005261) | 3.41729256 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.26073029 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.24355610 |
| 33 | Papillary thyroid carcinoma (HP:0002895) | 3.21996443 |
| 34 | Hypoglycemic seizures (HP:0002173) | 3.19558747 |
| 35 | Chromsome breakage (HP:0040012) | 3.13993383 |
| 36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.08029013 |
| 37 | Abnormal lung lobation (HP:0002101) | 3.00448455 |
| 38 | Hyperglycinuria (HP:0003108) | 2.96260064 |
| 39 | Rhabdomyosarcoma (HP:0002859) | 2.95554408 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.89209318 |
| 41 | Abnormality of complement system (HP:0005339) | 2.86930508 |
| 42 | Hypercholesterolemia (HP:0003124) | 2.86439570 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.85873023 |
| 44 | Medulloblastoma (HP:0002885) | 2.77316595 |
| 45 | Thyroid carcinoma (HP:0002890) | 2.75872019 |
| 46 | Abnormality of chromosome stability (HP:0003220) | 2.74410088 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.71834278 |
| 48 | Abnormality of glycolysis (HP:0004366) | 2.62177680 |
| 49 | Increased serum pyruvate (HP:0003542) | 2.62177680 |
| 50 | Myocardial infarction (HP:0001658) | 2.58893177 |
| 51 | Hyperbilirubinemia (HP:0002904) | 2.56939799 |
| 52 | Ketoacidosis (HP:0001993) | 2.56263497 |
| 53 | Hypoplastic pelvis (HP:0008839) | 2.55113455 |
| 54 | Myelodysplasia (HP:0002863) | 2.53834330 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.51770531 |
| 56 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.51654230 |
| 57 | Large earlobe (HP:0009748) | 2.47110832 |
| 58 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.45049600 |
| 59 | Long clavicles (HP:0000890) | 2.41536692 |
| 60 | Skin nodule (HP:0200036) | 2.41415452 |
| 61 | Deep philtrum (HP:0002002) | 2.41290350 |
| 62 | Symptomatic seizures (HP:0011145) | 2.40701504 |
| 63 | Termporal pattern (HP:0011008) | 2.39499692 |
| 64 | Insidious onset (HP:0003587) | 2.39499692 |
| 65 | Curly hair (HP:0002212) | 2.38798158 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.37460074 |
| 67 | Embryonal renal neoplasm (HP:0011794) | 2.35946647 |
| 68 | Vascular calcification (HP:0004934) | 2.35218169 |
| 69 | Neurofibrillary tangles (HP:0002185) | 2.35068773 |
| 70 | Degeneration of anterior horn cells (HP:0002398) | 2.34292583 |
| 71 | Abnormality of the anterior horn cell (HP:0006802) | 2.34292583 |
| 72 | Hyperglycemia (HP:0003074) | 2.32802154 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.32293937 |
| 74 | Proximal placement of thumb (HP:0009623) | 2.30998908 |
| 75 | Abnormal hair whorl (HP:0010721) | 2.30799653 |
| 76 | Cystic hygroma (HP:0000476) | 2.28809090 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.28241472 |
| 78 | Opisthotonus (HP:0002179) | 2.27798712 |
| 79 | Overlapping toe (HP:0001845) | 2.27565940 |
| 80 | Acanthocytosis (HP:0001927) | 2.27327851 |
| 81 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.25223633 |
| 82 | Spastic paraparesis (HP:0002313) | 2.24898282 |
| 83 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.23264536 |
| 84 | Protuberant abdomen (HP:0001538) | 2.21766914 |
| 85 | Freckling (HP:0001480) | 2.20792072 |
| 86 | Deviation of the thumb (HP:0009603) | 2.20226992 |
| 87 | Dicarboxylic aciduria (HP:0003215) | 2.18957493 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18957493 |
| 89 | Metabolic acidosis (HP:0001942) | 2.18787991 |
| 90 | Abnormality of the preputium (HP:0100587) | 2.16184840 |
| 91 | Small intestinal stenosis (HP:0012848) | 2.15041361 |
| 92 | Duodenal stenosis (HP:0100867) | 2.15041361 |
| 93 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13872701 |
| 94 | Meckel diverticulum (HP:0002245) | 2.13597129 |
| 95 | Lethargy (HP:0001254) | 2.13507480 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.12535486 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.12322985 |
| 98 | Glioma (HP:0009733) | 2.11739559 |
| 99 | Spontaneous abortion (HP:0005268) | 2.11140063 |
| 100 | Abnormality of the astrocytes (HP:0100707) | 2.10603424 |
| 101 | Astrocytoma (HP:0009592) | 2.10603424 |
| 102 | Abnormality of chromosome segregation (HP:0002916) | 2.10436015 |
| 103 | Irritability (HP:0000737) | 2.09417067 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 2.08197235 |
| 105 | Cerebral edema (HP:0002181) | 2.06883159 |
| 106 | Abnormality of the metopic suture (HP:0005556) | 2.06556610 |
| 107 | Hypophosphatemic rickets (HP:0004912) | 2.06169197 |
| 108 | Septate vagina (HP:0001153) | 2.04820255 |
| 109 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.04679360 |
| 110 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.04679360 |
| 111 | Sloping forehead (HP:0000340) | 2.04259161 |
| 112 | Pancreatitis (HP:0001733) | 2.01568643 |
| 113 | Hydroxyprolinuria (HP:0003080) | 2.01313541 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 2.01313541 |
| 115 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.01123176 |
| 116 | Gonadotropin excess (HP:0000837) | 1.99598713 |
| 117 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.99481706 |
| 118 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.99481706 |
| 119 | Parakeratosis (HP:0001036) | 1.97975431 |
| 120 | Microvesicular hepatic steatosis (HP:0001414) | 1.97496909 |
| 121 | Bifid tongue (HP:0010297) | 1.97444449 |
| 122 | Abnormality of urine glucose concentration (HP:0011016) | 1.97186494 |
| 123 | Glycosuria (HP:0003076) | 1.97186494 |
| 124 | Spastic diplegia (HP:0001264) | 1.95836499 |
| 125 | Abnormality of the ileum (HP:0001549) | 1.95074663 |
| 126 | Abnormality of the duodenum (HP:0002246) | 1.94281562 |
| 127 | Shoulder girdle muscle weakness (HP:0003547) | 1.93938634 |
| 128 | Abnormal foot bone ossification (HP:0010675) | 1.93065898 |
| 129 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.91403882 |
| 130 | Blepharitis (HP:0000498) | 1.90573695 |
| 131 | Mitral stenosis (HP:0001718) | 1.90248232 |
| 132 | Cafe-au-lait spot (HP:0000957) | 1.88432637 |
| 133 | Limb hypertonia (HP:0002509) | 1.87833424 |
| 134 | Birth length less than 3rd percentile (HP:0003561) | 1.87188850 |
| 135 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.85552103 |
| 136 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.85552103 |
| 137 | Back pain (HP:0003418) | 1.85124926 |
| 138 | Ependymoma (HP:0002888) | 1.84408337 |
| 139 | Pheochromocytoma (HP:0002666) | 1.84025149 |
| 140 | Esophageal varix (HP:0002040) | 1.83662427 |
| 141 | Facial hemangioma (HP:0000329) | 1.83375616 |
| 142 | Neoplasm of striated muscle (HP:0009728) | 1.82742800 |
| 143 | Malnutrition (HP:0004395) | 1.81775579 |
| 144 | Axonal loss (HP:0003447) | 1.81638422 |
| 145 | Epiphyseal stippling (HP:0010655) | 1.81315703 |
| 146 | Late onset (HP:0003584) | 1.79410883 |
| 147 | Cutis marmorata (HP:0000965) | 1.79156041 |
| 148 | Increased mean platelet volume (HP:0011877) | 1.78904549 |
| 149 | Prominent metopic ridge (HP:0005487) | 1.78842380 |
| 150 | Neuroendocrine neoplasm (HP:0100634) | 1.78285945 |
| 151 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.76613976 |
| 152 | Micropenis (HP:0000054) | 1.76364000 |
| 153 | Combined immunodeficiency (HP:0005387) | 1.76204246 |
| 154 | Rickets (HP:0002748) | 1.75588417 |
| 155 | Enlarged kidneys (HP:0000105) | 1.75468018 |
| 156 | Abnormal cartilage morphology (HP:0002763) | 1.74708805 |
| 157 | Heterotopia (HP:0002282) | 1.74317180 |
| 158 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74196928 |
| 159 | Coronal craniosynostosis (HP:0004440) | 1.74012457 |
| 160 | Neoplasm of the oral cavity (HP:0100649) | 1.73514836 |
| 161 | Glomerulonephritis (HP:0000099) | 1.73317605 |
| 162 | Systemic lupus erythematosus (HP:0002725) | 1.73012159 |
| 163 | Elevated alkaline phosphatase (HP:0003155) | 1.73012128 |
| 164 | Decreased testicular size (HP:0008734) | 1.72153484 |
| 165 | Hypochromic microcytic anemia (HP:0004840) | 1.71141670 |
| 166 | Metaphyseal cupping (HP:0003021) | 1.70566453 |
| 167 | Median cleft lip (HP:0000161) | 1.70423192 |
| 168 | Paraparesis (HP:0002385) | 1.70013180 |
| 169 | Abnormality of macular pigmentation (HP:0008002) | 1.69728910 |
| 170 | Thickened nuchal skin fold (HP:0000474) | 1.68942774 |
| 171 | Missing ribs (HP:0000921) | 1.68564559 |
| 172 | Cholelithiasis (HP:0001081) | 1.68554996 |
| 173 | Renal cortical cysts (HP:0000803) | 1.68334981 |
| 174 | Pelvic girdle muscle weakness (HP:0003749) | 1.68190773 |
| 175 | Abnormality of vitamin metabolism (HP:0100508) | 1.67942404 |
| 176 | Short tibia (HP:0005736) | 1.66432013 |
| 177 | Colon cancer (HP:0003003) | 1.66307235 |
| 178 | Postnatal growth retardation (HP:0008897) | 1.65411635 |
| 179 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 1.64121586 |
| 180 | Acute myeloid leukemia (HP:0004808) | 1.63053194 |
| 181 | Uterine leiomyosarcoma (HP:0002891) | 1.62660940 |
| 182 | Leiomyosarcoma (HP:0100243) | 1.62660940 |
| 183 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.62115292 |
| 184 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.61335666 |
| 185 | Autoamputation (HP:0001218) | 1.61257658 |
| 186 | Ovarian neoplasm (HP:0100615) | 1.60893424 |
| 187 | Drooling (HP:0002307) | 1.59786622 |
| 188 | Postnatal microcephaly (HP:0005484) | 1.58669410 |
| 189 | Neoplasm of the colon (HP:0100273) | 1.58492775 |
| 190 | Skull defect (HP:0001362) | 1.58359804 |
| 191 | Relative macrocephaly (HP:0004482) | 1.58347514 |
| 192 | Amyotrophic lateral sclerosis (HP:0007354) | 1.58324498 |
| 193 | Abnormality of the carotid arteries (HP:0005344) | 1.57906131 |
| 194 | Microglossia (HP:0000171) | 1.57702999 |
| 195 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.56453054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.86417084 |
| 2 | SRPK1 | 3.65858499 |
| 3 | STK39 | 3.28320970 |
| 4 | BMPR1B | 3.22988728 |
| 5 | LATS1 | 3.22598367 |
| 6 | BUB1 | 3.18989779 |
| 7 | PBK | 3.10888976 |
| 8 | WEE1 | 3.04769368 |
| 9 | NEK9 | 3.01177587 |
| 10 | TSSK6 | 2.97791432 |
| 11 | ERBB4 | 2.92751910 |
| 12 | NEK1 | 2.81689061 |
| 13 | BCR | 2.77663143 |
| 14 | EPHB1 | 2.66465629 |
| 15 | TRIM28 | 2.58074712 |
| 16 | CDC7 | 2.57803343 |
| 17 | MET | 2.54789744 |
| 18 | LIMK1 | 2.52216350 |
| 19 | ERN1 | 2.36870814 |
| 20 | NUAK1 | 2.31395486 |
| 21 | TESK2 | 2.29174536 |
| 22 | FGFR4 | 2.16662054 |
| 23 | OXSR1 | 2.07124866 |
| 24 | FGFR2 | 1.98889741 |
| 25 | MKNK1 | 1.96683281 |
| 26 | INSRR | 1.96600638 |
| 27 | TAOK3 | 1.96226927 |
| 28 | PNCK | 1.88939078 |
| 29 | PLK3 | 1.84835855 |
| 30 | AKT3 | 1.60670193 |
| 31 | MST4 | 1.55296294 |
| 32 | SIK1 | 1.51333978 |
| 33 | STK38L | 1.50037246 |
| 34 | SIK3 | 1.47516707 |
| 35 | MAP3K4 | 1.47263551 |
| 36 | BRD4 | 1.42252940 |
| 37 | EIF2AK2 | 1.42211978 |
| 38 | MKNK2 | 1.39442701 |
| 39 | PLK1 | 1.31370847 |
| 40 | CSNK1A1L | 1.30867216 |
| 41 | CLK1 | 1.29524838 |
| 42 | FLT3 | 1.23328039 |
| 43 | CSNK1G3 | 1.22622339 |
| 44 | CDK8 | 1.20954275 |
| 45 | ATR | 1.19780259 |
| 46 | PIK3CG | 1.17363886 |
| 47 | TIE1 | 1.16757259 |
| 48 | RPS6KA4 | 1.14909977 |
| 49 | STK3 | 1.13844325 |
| 50 | EIF2AK1 | 1.12830284 |
| 51 | FRK | 1.11842767 |
| 52 | PIK3CA | 1.10061305 |
| 53 | DYRK3 | 1.09665675 |
| 54 | WNK4 | 1.07158746 |
| 55 | DYRK2 | 1.06361201 |
| 56 | MAP3K13 | 1.05146718 |
| 57 | EPHB2 | 1.04335350 |
| 58 | CCNB1 | 1.03996367 |
| 59 | TESK1 | 1.03445806 |
| 60 | CSNK1G2 | 1.03134929 |
| 61 | ACVR1B | 1.03084189 |
| 62 | AURKB | 1.02292460 |
| 63 | ATM | 1.01608111 |
| 64 | WNK3 | 1.00981590 |
| 65 | CSNK1G1 | 0.98774876 |
| 66 | PAK3 | 0.97708426 |
| 67 | IRAK3 | 0.97173244 |
| 68 | CDK9 | 0.97078331 |
| 69 | CHEK1 | 0.96689211 |
| 70 | ERBB3 | 0.95843240 |
| 71 | STK16 | 0.95626125 |
| 72 | PASK | 0.95138596 |
| 73 | CHEK2 | 0.95063651 |
| 74 | STK10 | 0.92891270 |
| 75 | TRPM7 | 0.90044699 |
| 76 | TRIB3 | 0.90000192 |
| 77 | CDK7 | 0.89488237 |
| 78 | MAP3K2 | 0.88152169 |
| 79 | ABL2 | 0.86636399 |
| 80 | PAK4 | 0.86330364 |
| 81 | SCYL2 | 0.83841484 |
| 82 | RAF1 | 0.83500293 |
| 83 | YES1 | 0.83485573 |
| 84 | NEK2 | 0.83466304 |
| 85 | MST1R | 0.80569504 |
| 86 | PLK4 | 0.80494867 |
| 87 | MAP2K7 | 0.79995160 |
| 88 | PKN1 | 0.79749202 |
| 89 | KSR1 | 0.79069962 |
| 90 | OBSCN | 0.74659586 |
| 91 | MUSK | 0.74448842 |
| 92 | MAP3K12 | 0.74022198 |
| 93 | NTRK1 | 0.73259982 |
| 94 | PTK6 | 0.72583800 |
| 95 | NEK6 | 0.67795860 |
| 96 | CDK3 | 0.65141434 |
| 97 | BRSK1 | 0.65007547 |
| 98 | CAMK2G | 0.63810912 |
| 99 | TEC | 0.60784565 |
| 100 | VRK1 | 0.60501855 |
| 101 | IRAK1 | 0.59564531 |
| 102 | ERBB2 | 0.59531254 |
| 103 | PRKCQ | 0.58516831 |
| 104 | EPHA3 | 0.58107084 |
| 105 | CDK1 | 0.57833813 |
| 106 | KSR2 | 0.56540201 |
| 107 | GSK3A | 0.54284654 |
| 108 | CAMK1D | 0.54251637 |
| 109 | TGFBR1 | 0.52473190 |
| 110 | SGK223 | 0.52444530 |
| 111 | SGK494 | 0.52444530 |
| 112 | ROCK2 | 0.52309186 |
| 113 | CDK2 | 0.52213725 |
| 114 | MAP3K8 | 0.51947711 |
| 115 | IGF1R | 0.51870976 |
| 116 | LRRK2 | 0.49442959 |
| 117 | FGFR1 | 0.46924624 |
| 118 | MOS | 0.46886027 |
| 119 | CSK | 0.46327340 |
| 120 | MAP2K2 | 0.46018048 |
| 121 | PRKAA2 | 0.45426104 |
| 122 | PLK2 | 0.44705909 |
| 123 | MAP2K1 | 0.44217929 |
| 124 | TTK | 0.43760042 |
| 125 | JAK2 | 0.43222082 |
| 126 | FER | 0.42410841 |
| 127 | CDK18 | 0.41620395 |
| 128 | MAPKAPK5 | 0.40572380 |
| 129 | CDK6 | 0.39103265 |
| 130 | PAK2 | 0.39039945 |
| 131 | MELK | 0.38710082 |
| 132 | MAP4K2 | 0.37369442 |
| 133 | BMPR2 | 0.36714384 |
| 134 | PRKACB | 0.36663117 |
| 135 | CSNK2A2 | 0.36579986 |
| 136 | PRKD1 | 0.36112181 |
| 137 | CSNK2A1 | 0.35869933 |
| 138 | PTK2 | 0.35824082 |
| 139 | PRKDC | 0.35324586 |
| 140 | CSNK1E | 0.35184228 |
| 141 | MINK1 | 0.33201970 |
| 142 | EIF2AK3 | 0.31963916 |
| 143 | RPS6KB1 | 0.30963834 |
| 144 | ZAK | 0.30184079 |
| 145 | CDK15 | 0.30114600 |
| 146 | AURKA | 0.29784469 |
| 147 | CDK12 | 0.28782069 |
| 148 | MAP3K14 | 0.27898396 |
| 149 | CDK14 | 0.27861582 |
| 150 | CAMK2D | 0.27851677 |
| 151 | BRSK2 | 0.27648847 |
| 152 | CAMK1G | 0.27500506 |
| 153 | CDK11A | 0.27417037 |
| 154 | CAMKK2 | 0.27319381 |
| 155 | BRAF | 0.26772858 |
| 156 | MAPK11 | 0.26663423 |
| 157 | MAP3K10 | 0.26263197 |
| 158 | ABL1 | 0.26182659 |
| 159 | ARAF | 0.25741107 |
| 160 | ICK | 0.24025224 |
| 161 | CAMK2B | 0.23860236 |
| 162 | CASK | 0.23255928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.69651463 |
| 2 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.68057922 |
| 3 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.53623749 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.43776776 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41272986 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.22611275 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.21899873 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 3.12481987 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.90507213 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.87162409 |
| 11 | Cell cycle_Homo sapiens_hsa04110 | 2.75112639 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.63025119 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.58716424 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.57731783 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.45869317 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44847762 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40737265 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.39051680 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36219743 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.35809740 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.35557322 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32774075 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.30050525 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 2.28907844 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.27431411 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.23479847 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15090996 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 2.12573121 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 2.09690871 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 2.07306718 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03491575 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.99916500 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.99342531 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95912882 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95025831 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94455285 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93180103 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88443130 |
| 39 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.82607648 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.78663075 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77528113 |
| 42 | RNA degradation_Homo sapiens_hsa03018 | 1.76365682 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.76251950 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68016569 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55898982 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.52777878 |
| 47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.51802929 |
| 48 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.51242146 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50120215 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.49585792 |
| 51 | Protein export_Homo sapiens_hsa03060 | 1.49382236 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.46184473 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43706073 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38964929 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 1.38834682 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.35486221 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 1.35394592 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33769393 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32351912 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.32036947 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30791322 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.30086779 |
| 63 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.29752531 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.28924425 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28911814 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28689829 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23732531 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20204663 |
| 69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19835389 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15656294 |
| 71 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08550853 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03547850 |
| 73 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.99489605 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98727077 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.98610266 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97318647 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95385081 |
| 78 | Adherens junction_Homo sapiens_hsa04520 | 0.95260646 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.92268064 |
| 80 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87598454 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.84399086 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78506964 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72747977 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.71832012 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70542285 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70350685 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.69247979 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68899113 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68599058 |
| 90 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67867981 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64732751 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64090897 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55864150 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.55816352 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54152005 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53350020 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53308985 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51791319 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.51695297 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51656729 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51484304 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51481362 |
| 103 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49722304 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49630945 |
| 105 | Hepatitis B_Homo sapiens_hsa05161 | 0.47281557 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47182861 |
| 107 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47112843 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46778797 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.45975119 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43536665 |
| 111 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43385250 |
| 112 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.42363629 |
| 113 | Measles_Homo sapiens_hsa05162 | 0.41885390 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.40970516 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.40599818 |
| 116 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.38742494 |
| 117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.38186732 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36032667 |
| 119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32088920 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31072430 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30070919 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29195023 |
| 123 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27426977 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25006429 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.24672782 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24628055 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.22925260 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21122767 |
| 129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.21024016 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20539487 |
| 131 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20378007 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19366066 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.18337254 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18249500 |
| 135 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.17737630 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.17512172 |
| 137 | * Lysosome_Homo sapiens_hsa04142 | 0.14920476 |
| 138 | Melanoma_Homo sapiens_hsa05218 | 0.14543200 |
| 139 | Phagosome_Homo sapiens_hsa04145 | 0.13738485 |
| 140 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12775678 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10013934 |
| 142 | Insulin resistance_Homo sapiens_hsa04931 | 0.07546076 |
| 143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.04625469 |
| 144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.04508458 |
| 145 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.04470922 |
| 146 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.00132325 |
| 147 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1176561 |
| 148 | Prostate cancer_Homo sapiens_hsa05215 | -0.1134174 |
| 149 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0988681 |
| 150 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0922094 |
| 151 | Hepatitis C_Homo sapiens_hsa05160 | -0.0756650 |
| 152 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0739195 |
| 153 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0476087 |
| 154 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0433350 |
| 155 | Tight junction_Homo sapiens_hsa04530 | -0.0401725 |
| 156 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0069592 |

